SCHEMBL3852095

SCHEMBL3852095

Cc1cc(NC(=O)c2ccc(-c3cnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cn34)cc2F)on1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
GLA P06280 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MET P08581 2/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
JAK3 P52333 1/20 0.37
CLK1 P49759 4/20 0.37
ATF1 P18846 1/20 0.36
NFKB1 P19838 1/20 0.36
KIT P10721 2/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
MTOR P42345 1/20 0.35
CDK19 Q9BWU1 1/20 0.35
MAPK1 P28482 3/20 0.34
FGFR3 P22607 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845914 0.89 MAPK1 (0.42) ALDH1A1SMN1; SMN2METMAPTCLK1
SCHEMBL3848697 0.86 ALDH1A1 (0.45) ALDH1A1METMAPTMAPK1
SCHEMBL3846730 0.85 IDO1 (0.40) METCLK1KITFGFR3KDR
SCHEMBL3845025 0.84 SORT1 (0.41) ALDH1A1SMN1; SMN2METCLK1NFKB1
SCHEMBL3852747 0.84 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2METCLK1FGFR3
SCHEMBL3851316 0.84 MET (0.41) METCLK1PIK3CAMAPK1FGFR3
SCHEMBL3852108 0.83 CYP1A2 (0.39) ALDH1A1SMN1; SMN2METMAPTCLK1
SCHEMBL3846961 0.83 TRPV1 (0.47) METMAPTCLK1KITFGFR3
SCHEMBL3847490 0.83 MAPT (0.40) ALDH1A1SMN1; SMN2METMAPTCLK1
SCHEMBL3849284 0.83 EPHB3 (0.38) METCLK1KITMAPK1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed